The Palmer Foundation

Tag: A Patient Story

A Judge Stands up to a Hospital: “Step Aside” and Give a Dying Man Ivermectin

24/11/2021 No Comments

The judge’s finest moment may have been when he dashed the most glaring myth about ivermectin—that it is not safe, despite decades of use that shows otherwise. Noting that all drugs have side effects, Judge Fullerton listed ivermectin’s effects from a government website.
“(N)umber one, generally well tolerated; number two, dizziness; number three, pruritus; number four, nausea/diarrhea. These are the side effects for the dosage that’s being asked to be administered,” he said. “The risks of these side effects are so minimal that Mr. Ng’s current situation outweighs that risk by one-hundredfold.”

Read More »

How Dr. Paul Marik Saved a Grandmother & The World (Part 3)

23/11/2021 No Comments

Recently Merck issued a stern warning that seemed written by marketing, Kory says, “as it had no scientific data to support the conclusion,” that ivermectin was suddenly dangerous. Another pharmaceutical company’s CEO privately noted that “People must think Merck knows what they’re talking about because it’s their drug,” but Merck has “tremendous disincentives” to say nice things about the generic pill, as it has already spent hundreds of millions of dollars developing an oral anti-viral COVID-19 treatment, rival to ivermectin, that may be priced at $3,000 a dose.

Read More »

How Dr. Paul Marik Saved a Grandmother & The World (Part 2)

20/11/2021 No Comments

They also restricted the use of essential off-label and generic drugs with blatant disinformation campaigns that reminded Kory of big tobacco’s efforts to hide the dangers of smoking. In effect, the public health authorities eliminated the full toolbox of essential scientific methods and drugs that doctors use every day, including the most effective early, prophylactic, and late-stage treatments for COVID-19, which were developed by frontline doctors, not pharmaceutical companies.

Read More »

Chronicle of a Covid death foretold – the battle for early treatment being waged behind enemy lines

31/07/2021 No Comments

Borody’s ivermectin triple therapy prophylactic is the perfect solution. It reduces transmission immediately, regardless of the variant, by preventing the virus from entering a person’s cells. It also shortens time spent in quarantine and reduces transmission to close contacts. Early treatment dramatically reduces hospitalisation and mortality and would rapidly end the Sydney wave, as similar therapies did in Mexico and India. It would also put an end to any need for masks and lockdowns.

Read More »

An Interview with Dr Vladimir Zelenko, MD

09/05/2021 No Comments

We are very honored to present this interview of Dr Vladimir Zelenko, the father of outpatient treatment for COVID-19 in North America. Dr Zelenko shares his own experience with COVID-19 as a patient, as he is recovering from a severe form of the disease.
He also talks about his cancer and how he was able to go through this dramatic episode of his life. Then, he presents his perspectives about outpatient treatment as practiced today and the evolution of the pandemic, among other topics.

Read More »

Another New York State Supreme Court Justice Ivermectin Order Helping 81-Year-Old Farmer

10/04/2021 No Comments

Ivermectin, a medicine for parasites, has been around for four decades. While not authorized for use against COVID-19, dozens of studies show materially positive results. At well-established human dosage levels, the drug is safe: hundreds of millions of people are treated with it every year mostly in the tropics for various parasite-borne diseases, such as River Blindness in Nigeria.

Read More »

Community Memorial Health Chief with COVID treated early at home with hydroxychloroquine

10/02/2021 No Comments

The suggested treatment protocol ideally begins when someone first tests positive for COVID-19. Patients are started on a daily “nutraceutical bundle” of zinc sulfate (220 mg), Vitamin D (5000 IU), Vitamin C (3000 mg), and a flavonoid called quercetin (500 mg), found in several fruits and vegetables, which reduces viral replication. All are available over the counter.
For those 50 years or older with one or more comorbidities, an intravenous infusion of monoclonal antibodies is suggested. In addition, the patient is immediately started on an array of anti-infective agents, which includes hydroxychloroquine, ivermectin, azithromycin, doxycycline, and favipiravir. Some patients are started on a steroid like prednisone, and some are given an anticoagulant.

Read More »
Share on facebook
Facebook
Share on twitter
Twitter

Copyright 2020 © The Palmer Foundation